Texas Tech University Health Sciences Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Texas Tech University Health Sciences Center sits in the top decile of US sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count).

76 total trials 10 currently recruiting 45 completed early-phase tilt top decile by trial count

Texas Tech University Health Sciences Center: 76 sponsored US clinical trials, 10 recruiting.

Texas Tech University Health Sciences Center sponsors 76 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 45 completed. 13 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postoperative Pain, with 3 trials.

Top-decile sponsor footprint

Texas Tech University Health Sciences Center ranks in the top decile of sponsors by registered trial count (#286 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

45 of 60 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

76 total, page 2 of 2

COMPLETED NA

Efficacy of Surgical Preparation Solutions in Knee Surgery

NCT01857349

COMPLETED Early Phase 1

Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)

NCT02114957

COMPLETED NA

The Change Cycle Intervention for Improving Quality of Life in Breast Cancer Survivors

NCT01734499

COMPLETED Phase 4

Pain Control With Total Knee Replacement

NCT01680549

COMPLETED NA

Women's Health Project for Women Wanting to Lose Weight

NCT01671397

COMPLETED Phase 4

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

NCT01537029

COMPLETED Phase 4

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

NCT01307930

COMPLETED Phase 1

Effect of Vitamin D Replacement on Insulin Sensitivity

NCT01268111

COMPLETED Phase 4

Effect of Weight and/or Obesity on Dapsone Drug Concentrations

NCT01165840

COMPLETED Phase 4

Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations

NCT01167452

COMPLETED Phase 4

Effect of Weight and/or Obesity on Caspofungin Drug Concentrations

NCT01062165

COMPLETED Phase 4

Effect of Weight and/or Obesity on Ethambutol Drug Concentrations

NCT01048697

TERMINATED Phase 2

Manual Therapy Versus Exercise on Knee Osteoarthritis

NCT00988468

TERMINATED NA

Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer

NCT00948285

COMPLETED

Antimicrobial Resistance of Bacteria in Burn Patients

NCT00794742

TERMINATED NA

Effect of Fenugreek on Milk Production

NCT00851591

COMPLETED NA

Interventional Study of Effects on Spine Height With Two Unloading Positions

NCT01048749

TERMINATED NA

Ultrasound for Diagnosis of Biliary Dyskinesia

NCT00737295

COMPLETED Phase 1

Green Tea and Tai Chi for Bone Health

NCT00625391

COMPLETED Phase 4

Direct Renin Inhibition Effects on Atherosclerotic Biomarkers

NCT00818779

TERMINATED NA

Use of High Frequency Chest Compression in Pediatric Status Asthmaticus

NCT00552448

TERMINATED

Dermabond Skin Adhesives vs Skin Staples for Closure of Repeat Cesarean Section Skin Incisions

NCT00505856

TERMINATED Early Phase 1

Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)

NCT00747630

TERMINATED

Association of PICP Serum Marker in Patients With LVSD

NCT00232388

COMPLETED

Study to Determine Racial and Gender Differences in Platelet Aggregation

NCT00233428

COMPLETED Phase 2

Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis

NCT01442779

← Previous Page 2 of 2

What is open in the Texas Tech University Health Sciences Center pipeline

10 recruiting of 76 indexed (13% open); 45 completed (59%).

Phase mix: 13 late (III/IV) vs 22 early (I/II) (early-phase heavy).

Top condition: Postoperative Pain (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Texas Tech University Health Sciences Center: open-pipeline peers nationwide

Peers matched on 76 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

Texas Tech University Health Sciences Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 10%15%20%25%30%35% Total trials Recruiting share Texas Tech University Health Sciences CenterIonis PharmaceuticalsMetroHealth Medical CenterUniversity of New MexiUniversity of HawaiiSidney Kimmel Comprehensive Cancer Center at Johns HopkinsFood and Drug Administration (FDA)Loyola UniversityVA Greater Los Angeles Healthcare System
Texas Tech University Health Sciences Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Texas Tech University Health Sciences Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 76 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this Texas Tech University Health Sciences Center page

76 registered trials is a research-attention snapshot, not an endorsement of Texas Tech University Health Sciences Center or any single study.

  • 10 of Texas Tech University Health Sciences Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Postoperative Pain is the condition Texas Tech University Health Sciences Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postoperative Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Texas Tech University Health Sciences Center pipeline card: 76 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.